Novavax (NVAX) EBT (2010 - 2026)
Novavax's (NVAX) quarterly EBT came in at -$8.5 million in Q1 2026, down 101.64% year-on-year from $519.8 million in Q1 2025, and down 147.51% quarter-over-quarter from $17.9 million in Q4 2025.
Novavax (NVAX) EBT (2010 - 2026) Analysis & Trends
Novavax's EBT history runs 17 years deep, the most recent figure standing at -$8.5 million for Q1 2026.
- On a quarterly basis, EBT fell 101.64% year-over-year to -$8.5 million in Q1 2026; TTM through Mar 2026 was -$86.2 million, a 117.64% decrease from a year earlier, with the FY2025 full-year figure at $442.2 million, up 350.36% from the prior year.
- EBT eased to -$8.5 million in Q1 2026 per NVAX's latest filing, from $17.9 million in the prior quarter.
- Across five years, EBT topped out at $519.8 million in Q1 2025 and bottomed at -$509.1 million in Q2 2022.
- The 5-year median for EBT is -$122.3 million (2024), against an average of -$55.3 million.
- Across the five-year window, EBT tumbled 242.05% in 2023 and surged 457.8% in 2025, its largest moves.
- Year by year, EBT stood at -$184.5 million in 2022, then advanced by 4.23% to -$176.7 million in 2023, then soared by 58.36% to -$73.6 million in 2024, then soared by 124.33% to $17.9 million in 2025, then tumbled by 147.51% to -$8.5 million in 2026.
- Per Business Quant, the three latest NVAX EBT figures stand at -$8.5 million (Q1 2026), $17.9 million (Q4 2025), and -$203.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | -8.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.51 Mn |
| Dec 31, 2025 | 17.90 Mn |
| Sep 30, 2025 | -203.04 Mn |
| Jun 30, 2025 | 107.45 Mn |
| Mar 31, 2025 | 519.85 Mn |
| Dec 31, 2024 | -73.58 Mn |
| Sep 30, 2024 | -122.33 Mn |
| Jun 30, 2024 | 164.59 Mn |
| Mar 31, 2024 | -145.29 Mn |
| Dec 31, 2023 | -176.70 Mn |
| Sep 30, 2023 | -131.47 Mn |
| Jun 30, 2023 | 57.87 Mn |
| Mar 31, 2023 | -292.72 Mn |
| Dec 31, 2022 | -184.51 Mn |
| Sep 30, 2022 | -166.14 Mn |
| Jun 30, 2022 | -509.07 Mn |
| Mar 31, 2022 | 206.07 Mn |
| Dec 31, 2021 | -829.68 Mn |
| Sep 30, 2021 | -316.39 Mn |
| Jun 30, 2021 | -348.77 Mn |